남성 복부비만 환자의 치험 1례

김길수,김동열,김동환,Kim, Kil-Soo,Kim, Dong-Yeol,Kim, Dong-Hwan 한방비만학회 2002 한방비만학회지 Vol.2 No.1

2001년 1월 3일부터 2001년 4월 14일까지 고도의 복부비만으로 판정받은 1례의 환자에서 체감의이인탕의 한약복용, 초저열량식이요법(600kcal), 유산소운동(6km/h속도의 속보60분),행동수정요법(평소보다 50% 증가된 활동량), 전기지방분해침(Lipodren)40분, Infared therapy,이침, Aqua-pt(수압마사지)등을 입원 및 통원치료로 시행하여 비만지표, 신체사이즈, 간기능 검사, 복부 전산화단층촬영 상에서 유의한 변화를 관찰하였기에 보고하는 바이다. We experienced a male patient who was diagnosed as very severe abdominal obesity. From the 3rd of January to the 14th of April we applied herbal medication(Tiganyiyiren-tang), very low calorie diet, aerobic exercise, behavioral therapy, electrolipolysis, infra-red therapy, auricular acupuncture, and aqua-massage to him. And we examined the changes of his height, weight, body composition, body size, liver functional test, abdominal CT finding. The food production of this year has decreased by 5 percent. His weight decreased by 28.2%, PIBW by 28.5%, BMI by 28.2%, PBF by 22.7%, and WHR by 15.9%. The circumference of upper extremity decreased by 25.7%, the circumference of the muscle of upper extremity by 18.2%, the circumference of chest by 20.5%, the circumference of abdomen by 29.5%, the circumference of hip by 17.4%, and the circumference of thigh by 15.9%. In the liver functional test GOT decreased from 42IU/l to 361U/I, GPT from 1211U/l to 48IU/I. Total cholesterol from 211mg/dl to 152mg/dl, and Trigliceride from 192mg/dl to 81 mg/dl. In the abdominal CT finding the amount of fat in the abdominal cavity decreased from $9732mm^2$ to $3639mm^2$.

Peroxisome Proliferator-Activated $Receptor-{\gamma}$ 2 $(PPAR{\gamma}2)$ Pro12Ala (P12A) 유전자 다형성이 한국여성의 체지방분포에 미치는 영향

김길수,최선미,양현성,윤유식,신승우,Kim, Kil-Soo,Choi, Sun-Mi,Yang, Hyun-Sung,Yoon, Yoo-Sik,Shin, Seun-Uoo 한방비만학회 2004 한방비만학회지 Vol.4 No.1

Objectives: The effects of peroxisome proliferator-activated receptor ${\gamma}2\;(PPAR{\gamma}2)$ Pro12Ala (P12A) polymorphism on body mass index (BMI) and type 2 diabetes are well documented; however, until now, only a few studies have evaluated the effects of this polymorphism on body fat distribution. This study was conducted to elucidate the effects of this polymorphism on computed tomography (CT)-measured body fat distribution and other obesity-related parameters in Korean female subjects. Methods & Results: The frequencies of $PPAR{\gamma}2$ genotypes were: PP type, 93.0%; PA type, 6.8%; and AA type, 0.2%. The frequency of the A allele was 0.035. Body weight (P .012), BMI (P .012), and waist-to-hip ratio (WHR) (P .001) were significantly higher in subjects with PA/AA compared with subjects with PP. When body composition was analyzed by bioimpedance analysis, lean body mass and body water content were similar between the 2 groups. However, body fat mass (P .003) and body fat percent (P .025) were significantly higher in subjects with PA/AA compared with subjects with PP. Among overweight subjects with BMI of greater than 25, PA/AA was associated with significantly higher abdominal subcutaneous fat (P .000), abdominal visceral fat (P .031), and subcutaneous upper and lower thigh adipose tissue (P .010 and .013). However, among lean subjects with BMI of less than 25, no significant differences associated with $PPAR{\gamma}2$ genotype were found, suggesting that the fat-accumulating effects of the PA/AA genotype were evident only among overweight subjects, but not among lean subjects. When serum lipid profiles, glucose, and liver function indicators were compared among overweight subjects, no significant difference associated with $PPAR{\gamma}2$ genotype was found. Changes in body weight, BMI, WHR, and body fat mass were measured among overweight subjects who finished a 1-month weight lose program of a hypocaloric diet and exercise; no significant differences associated with $PPAR{\gamma}2$ genotype were found. Conclusions: The results of this study suggest that the $PPAR{\gamma}2$ PA/AA genotype is associated with increased subcutaneous and visceral fat areas in overweight Korean female subjects, but does not significantly affect serum biochemical parameters and outcomes of weight loss programs.

1-naphthylisothiocyanate에 기인된 랫드의 간내성 담즙분비 정지에 대한 인진호(Artemisia messes-schmidiana var viridis)의 지질 및 조직병리학적 영향

김길수,정영길,김무강,Kim, Kil-soo,Jeong, Young-gil,Kim, Moo-kang 대한수의학회 1995 大韓獸醫學會誌 Vol.35 No.3

Artemisia messes-schmidiana var viridis(Compositae) has been used for jaundice, hepatitis, diuretic and liver cirrhosis etc. 1-naphthylisothiocyanate(ANIT) has been used as a model compound to study mechanisms of intrahepatic cholestasis in laboratory animals as rat and mouse. The purposes of present study are to examine pharmacological effects of Artemisia messes-schmidiana var viridis water extract(AMWE) on alterations of triacylglycerol, cholesterol, protein, albumin and A/G ratio levels in serum, of histopathological appearances of liver, and that of hepatic microsomal cytochrome P-450 contents. Increased serum triacylglycerol levels by ANIT were significantly decreased with AMWE. However, AMWE posttreatment aggravated ANIT-induced cholesterol increase. Serum total protein and albumin contents, and A/G ratio were decreased in all ANIT-treated groups, and there were increased compared with control by AMWE posttreatment. Hepatic microsomal cytochrome P-450 contents were decreased in either AMWE and ANIT treatment, which greatly increased with AMWE pretreatment. On the other hand, in histological findings, our results shown that ANIT induced increase of lipid droplets and widening of sinusoidal capillary and these phenomena were disappeared with AMWE treatment. In conclusion, AMWE have choleresis effect. Also, AMWE improved lipid metabolism, protection and regeneration of hepatocytes in ANIT-induced cholestasis.

컴퓨터와 선진국

김길수,Kim, Gil-Su 한국IT전문가협회 1987 소프트웨어세계 Vol.1 No.-

Antioxidant and hepatoprotective effect of fermented red ginseng against liver injury in hyperlipidemia rats

김길수,Ki-Jun Nam,Jeong-Mu Cheon,Mi-Ree Lee,Dae-Whan Kim,Mi-Mi Seo,Myeong-Hwan Kim 한국실험동물학회 2015 한국실험동물학회 학술발표대회 논문집 Vol.2015 No.2

사염화탄소에 의한 랫드의 간손상에 대한 인진호메타놀추출물의 억제효과

김길수,박준형,Kim, Kil-soo,Park, Joon-hyoung 대한수의학회 1994 大韓獸醫學會誌 Vol.34 No.3

The purpose of present study was to examine pharmacological effect of Artemisia Iwayomogi methanol extract(AIME) on biochemical parameters(activities of AST, ALT, LDH, and ALP, contents of total bilirubin, total protein, albumin and A/G ratio in serum and levels of hepatic microsomal lipid peroxide and glucose-6-phosphatase activities) against hepatic injury by carbon tetrachloride($CCl_4$) in rats. Increased AST, ALT and LDH activities by $CCl_4$ were decreased in AIMS treatment group at 48 or 72 hours. Together, increased ALP activity by $CCl_4$ almost returned toward normal value in AIME treatment group at 72 hours. Serum total bilirubin contents increased to 87, 79 and 31% compared with normal group by $CCl_4$ which were decreased to 64, 42 and 26% in AIME treatment group at 24, 48 and 72 hours, respectively. Decreased contents of total protein and albumin, and A/G ratio by $CCl_4$ were recovered in AIME treatment group. Hepatic microsomal lipid peroxide levels(nmol malonic dialdehyde/100mg protein) increased to 140, 95 and 78% compared with normal group by $CCl_4$ which were decreased to 107, 74 and 65% in AIME treatment group at 24, 48 and 72 hours, separately. Hepatic microsomal glucose-6-phosphatase activities decreased to 60, 50 and 53% compared with normal group by $CCl_4$ at 24, 48 and 72 hours, respectively, which were increased at 72 hours in AIME treatment group. In conclusion, AIME enhanced the amelioration process from $CCl_4$-induced lipid peroxidation, degeneration of liver cell, and impairment of protein and bilirubin metabolisms.

원저 : 돼지의 기관분비에서 Sulfadiazine 과 Trimethoprim 의 약물동태학

김길수,윤효인 (Kil Soo Kim and Hyo In Yun) 한국임상수의학회 1997 한국임상수의학회지 Vol.14 No.1

체감의이인탕(體減薏苡仁湯)이 비만유도 흰쥐의 체중, 지방조직, 혈액변화, leptin과 Uncoupled protein에 미치는 영향

김길수,송재철,Kim, Kil-Su,Song, Jae-Chul 한방비만학회 2001 한방비만학회지 Vol.1 No.1

In Oriental medicine, there has been a theory that the deficiency of the Qi(氣) and the Phlegm(濕)-Damp(痰) bring Obesity. And so a clinically representative herb-medicine of the obesity treatments is Chegameyiin-tang . We observed the effects of Chegameyiin-tang on the fat tissues and what the function of Chegameyiin-tang is. These experimental studies were designed to investigate the effects of Chegameyiin-tang on the weight and lipid metabolism of obesity rats induced by high fat diet. And what is changed in the blood and how the leptin and uncoupled protein is affected. The measurement has been performed on (1) the weight of obese rats fed high fat diet, (2) the average size and number of epididymal fat cells, (3) the total cholesterol, triglyceride, glucose. and free fatty acids in the blood. and (4) the leptin and uncoupled protein in the blood are observed. The results are as follows; 1. In the sample group, the weight decrease occured significantly throughout the whole research period than that of control group. 2. In the sample group, epididymal fat weight showed significantly decrease in the 8th and 14th weeks than that of control group.3. In the sample group, epididymal fat cell size was decreased significantly in the 8th and 14th weeks than that of control group. 4. In the sample group, total cholesterol. triglyceride and glucose increased rather than control group in 8 weeks, those decreased significantly in 14 weeks. 5. In the sample group, free fatty acids and insulin increased rather than control group in 8 weeks. those showed some decrease in 14 weeks . 6. In the sample group, leptin decreased significantly than control group in 8, 14 weeks. Uncoupled protein showed some decrease in 8 weeks. that decreased significantly in 14 weeks.

초저열량 식이와 한방비만치료를 통한 당뇨 개선 1례 보고

김길수,김호준,Kim, Kil-Soo,Kim, Ho-Jun 한방비만학회 2002 한방비만학회지 Vol.2 No.1

Increasing body weight is closely associated with increasing risk for glucose intolerance and type II diabetes. Especially, abdominal distribution of weight and visceral obesity also seriously increase the morbidity and mortality. Dietary program including very-low-calorie diet(VLCD) is regarded as most effective in the control of obesity and diabetes, which mainly due to calorie restriction rather than weight loss itself. We are reporting a case of diabetes with obesity whose fast glucose was over 220 mg/dl and BMI was $25.1kg/m^2$(fat rate 32.8%, WHR 0.9). She was prescribed VLCD and oriental medical diet program. After 10 days of hospitalization, her glucose level dropped dramatically with 3kg loss of body weight She has further lost her weight until about 53kg, but the glucose level ceased to go down probably due to loosened calorie restriction.

초저열량 식이요법과 체감의이인탕의 병행치료가 비만 환자의 신체조성에 미치는 영향

김길수,김동열,Kim, Gil-Su,Kim, Dong-Yeol 한방비만학회 2001 한방비만학회지 Vol.1 No.1

Objectives: The aim of this study was to the effect of very low calorie diet with Chegameuiintang to treat obese patients . Methods: We have evaluated 54 obese patients during very low calorie diet with Chegameuiintang weight-reducing regime by determining the body composition before and 1 month, 2 months after treatment by Bioelectrical impedence analysis . Results: In the change of body composition by the treatment, mean weight reduction was 11.59kg(15.57% of initial weight), mean weight reduction after 1month was 7.68kg( 10.31% of initial weight), mean weight reduction after 2 months was 3.91 kg(5.86% of weight after 1 month). Mean reduction in total fat mass was 8.03kg(2914% of the initial fat mass) which constitutes 69.28%. Mean reduction in lean body mass was 3.56kg(7.59%) Conclusions: This study has demonstrated that the compound therapy of very low calorie diet and Chegameuiintang (Tiganyiyiren-tang) is the good way of weight reduction, which reduces total fat mass and preserves lean body mass.